Stevenage Bioscience Catalyst (SBC) has won University College London’s prestigious Small and Medium Enterprise Partner of the Year Award.
The awards recognise the efforts and accomplishments of UCL’s partner organisations in furthering enterprise and entrepreneurship at the university and forging close ties between academia and industry. UCL is driven to engage more closely with the biotechnology and pharmaceutical industries in SBC’s open innovation environment for developing solutions to improve patients’ health and quality of life.
SBC is a unique bioscience open innovation hub that emphasises collaboration, offering small biotech and life sciences companies and start-ups access to experts, networks and facilities that are usually only accessible from within large multi-national companies. The ecosystem hosts over 40 companies ranging from large corporates such as GlaxoSmithKline to academic representation of UCL and Cambridge University.
Dr Martino Picardo, CEO Stevenage Bioscience Catalyst, said:
“Our aim has been to create, develop and nurture new start-up businesses to build strong links between academia and industry through partnerships at an early stage. It’s a really great honour and a privilege to win this award and we’re very grateful to UCL for recognising our contributions to SMEs and the building of an ecosystem that is different to anything else in the UK, and we hope for their continued support moving forward.”
Some of the examples of this culture of collaboration includes:
• MRC Technology and SBC-based Peptinnovate which is researching on therapeutics for bone diseases with MRC Technology, which is due to relocate to the Catalyst in 2016.
• SBC tenant Avacta Life Sciences which has entered into a collaboration, licensing and option agreement with Moderna Therapeutics, Inc. ('Moderna')
And SBC is celebrating another success after Auspherix announced its is to establish its UK operations at the Catalyst. Read more here.
The LEP as part of its committment to key sectors which will grow the local economy secured £3m in its Growth Deal to accelerate the second phase of development at SBC.